Clinical Trial Update: A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) [Phase 3]

View source ↗

Summary

Phase III randomized, double-blind study evaluating anti-HIV immune serum globulin (HIVIG) to prevent maternal-to-child HIV transmission in pregnant women recei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIVIG (anti-HIV immune serum globulin)

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: HIV Infections, Pregnancy | Phase 3 | Status: COMPLETED